🔎 Trials Near Me

Почетна › Akutna bifentipska leukemija › Њујорк › New York City

Kliničke studije za Akutna bifentipska leukemija u gradu New York City, NY

10 studija za Akutna bifentipska leukemija traži učesnike na lokacijama u gradu New York City i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Тражи се учесникФаза 2
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • Memorial Sloan Kettering Cancer Center, New York
  • NYP/Weill Cornell Medical Center, New York
365 Days · Оба пола · Ажурирано 27. 10. 2026. · NCT06317662

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

Тражи се учесникФаза 1
  • Memorial Sloan- Kettering Cancer Center, New York
Узраст од 1 до 30 · Оба пола · Ажурирано 22. 10. 2026. · NCT06177067

A Study of Revumenib and Mezigdomide in People With Leukemia

Тражи се учесникФаза 1/2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Узраст 12 и старији · Оба пола · Ажурирано 20. 10. 2026. · NCT07356154

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Тражи се учесникФаза 1/2
  • Montefiore Medical Center, New York
30 Days · Оба пола · Ажурирано 9. 10. 2026. · NCT04065399

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Тражи се учесникФаза 1
  • Memorial Sloan Kettering Cancer Center, New York
Узраст од 12 до 78 · Оба пола · Ажурирано 29. 9. 2026. · NCT03802695

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Тражи се учесникФаза 3
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • Mount Sinai Hospital, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • и још 2
365 Days – 25 Years · Оба пола · Ажурирано 25. 8. 2026. · NCT03959085

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Тражи се учесникФаза 1/2
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
До 22 година · Оба пола · Ажурирано 25. 8. 2026. · NCT04726241

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Тражи се учесникФаза 2
  • Weill Cornell Medicine - New York Presbyterian Hospital, New York
Узраст 18 и старији · Оба пола · Ажурирано 7. 7. 2026. · NCT07216443

Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL

Тражи се учесникФаза 1
  • Memorial Sloan Kettering Cancer Center, New York
Узраст 12 и старији · Оба пола · Ажурирано 8. 1. 2026. · NCT04872478

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Тражи се учесникФаза 1
  • Children's Hospital New York-Presbyterian, New York
  • Memorial Sloan Kettering Cancer Center, New York
Узраст од 1 до 21 · Оба пола · Ажурирано 6. 12. 2024. · NCT05476770

Studije za Akutna bifentipska leukemija u drugim gradovima

Ostale studije u gradu New York City

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.